-
Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling and IL-2 release
de Jong, M., Veth, M., Brachtlová, T., King, L. A., Saura-Esteller, J., Bechler, T. M., van Helden, P. M., Alhan, C., Lameris, R., de Gruijl, T. D. & van der Vliet, J. J., 28 Jun 2026, In: Journal for Immunotherapy of Cancer. 14, 6Research output: Contribution to Journal › Article › Academic › peer-review
-
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia
Westra, N., Cerro, E. R., Schilder, E., Lub-de Hooge, M. N., Touw, D. J., Kosterink, J. G. W., Chitu, D. A., Ammatuna, E., Klein, S. K., Westerweel, P. E., Cuijpers, M., Cruijsen, M., Corsten, M. M. F., Alhan, C., Tick, L., Schuringa, J. J., Huls, G., Woolthuis, C. M. & Oude Munnink, T. H., 1 May 2026, In: Blood Neoplasia. 3, 2, 100218.Research output: Contribution to Journal › Article › Academic › peer-review
-
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies
Veenstra, C. R., Ngai, L. L., Gradowska, P., Versluis, J., Reuvekamp, T., Kelder, A., Scholten, W., Snel, S., Tettero, J. M., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R. & Porkka, K. & 7 others, , May 2026, In: HemaSphere. 10, 5, e70379.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
